Is the Xen® Gel Stent really minimally invasive?

Endophthalmitis Glaucoma Intraocular pressure Trabeculectomy Xen®

Journal

American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 17 04 2020
revised: 22 07 2020
accepted: 26 07 2020
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 15 8 2020
Statut: epublish

Résumé

To describe a case of severe A 64-year-old woman with open-angle glaucoma developed severe endophthalmitis 21 months after Xen® Gel Stent implantation. On presentation, visual acuity was limited to light perception. Examination revealed a 100% hypopyon, blebitis and an exposed stent, along with orbital cellulitis. Immediate explantation of the exposed Xen® was performed, and intravitreal antibiotics were administered. As for other filtering surgeries, blebitis and severe endophthalmitis can occur after Xen® Gel Stent implantation. Patients with thin conjunctiva and/or cystic blebs over the stent should be followed particularly closely.

Identifiants

pubmed: 32793844
doi: 10.1016/j.ajoc.2020.100850
pii: S2451-9936(20)30165-1
pii: 100850
pmc: PMC7415825
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100850

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The following authors have no financial disclosures: JB, CB, AL.

Références

Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):765-771
pubmed: 29356886
J Glaucoma. 2018 Dec;27(12):e191-e194
pubmed: 30180015
J Glaucoma. 2019 Jan;28(1):75-79
pubmed: 30461555
Ophthalmologica. 2013;230(2):93-9
pubmed: 23774034
J Glaucoma. 2019 Mar;28(3):e37-e40
pubmed: 30676470
J Fr Ophtalmol. 2019 Feb;42(2):e37-e46
pubmed: 30683533
Bull World Health Organ. 2004 Nov;82(11):887-8
pubmed: 15640929
Ophthalmology. 2001 Jul;108(7):1323-7
pubmed: 11425695
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Clin Ophthalmol. 2016 Jan 28;10:189-206
pubmed: 26869753
Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
pubmed: 12049574
Br J Ophthalmol. 2012 Jul;96(7):971-5
pubmed: 22334138
Int Ophthalmol. 2018 Jun;38(3):1129-1134
pubmed: 28555256
Am J Ophthalmol. 2000 Oct;130(4):429-40
pubmed: 11024415
Ophthalmology. 2017 Nov;124(11):1579-1588
pubmed: 28601250
Eur J Ophthalmol. 2019 Apr 25;:1120672119845226
pubmed: 31018685
Ophthalmology. 2018 Feb;125(2):209
pubmed: 29389405
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904
J Glaucoma. 2018 Oct;27(10):931-933
pubmed: 29952822
Ophthalmology. 2014 May;121(5):1001-6
pubmed: 24424248
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002897
pubmed: 16235305
Am J Ophthalmol. 2018 May;189:96-101
pubmed: 29499173

Auteurs

Juliette Buffault (J)

Department of Ophthalmology III, National Hospital Centre for Ophthalmology Quinze-Vingts, IHU FOReSIGHT, 28 rue de Charenton, F-75012, Paris, France.

Christophe Baudouin (C)

Department of Ophthalmology III, National Hospital Centre for Ophthalmology Quinze-Vingts, IHU FOReSIGHT, 28 rue de Charenton, F-75012, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, Université de Versailles Saint-Quentin en Yvelines, 9 Avenue Charles de Gaulle, F-92100, Boulogne, Billancourt, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Antoine Labbé (A)

Department of Ophthalmology III, National Hospital Centre for Ophthalmology Quinze-Vingts, IHU FOReSIGHT, 28 rue de Charenton, F-75012, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, Université de Versailles Saint-Quentin en Yvelines, 9 Avenue Charles de Gaulle, F-92100, Boulogne, Billancourt, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Classifications MeSH